🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Larry Robbins’s BIIB Holdings & Trades

First Buy
Q4 2025
Duration Held
4 Quarters
Largest Add
Q4 2025
+290,605 Shares
Current Position
68,169 Shares
$15.4 M Value

Larry Robbins's BIIB Position Overview

Larry Robbins (via Glenview Capital Management, LLC) currently holds 68,169 shares of Biogen Inc. (BIIB) worth $15.4 M, representing 0.25% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 4 quarters.

Based on 13F filings, Larry Robbins has maintained this position in BIIB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 68,169 shares. Largest reduction occurred in Q1 2026, reducing 233,586 shares.

Analysis based on 13F filings available since 2013 Q2

Larry Robbins's Biogen (BIIB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Biogen (BIIB) Trades by Larry Robbins

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +68,169 New Buy 68,169 $225.88
Q2 2026 -57,019 Sold Out 0 $0.00
Q1 2026 -233,586 Reduce 80.38% 57,019 $183.33
Q4 2025 +290,605 New Buy 290,605 $175.99

Larry Robbins's Biogen Investment FAQs

Larry Robbins first purchased Biogen Inc. (BIIB) in Q4 2025, acquiring 290,605 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Larry Robbins has held Biogen Inc. (BIIB) for 4 quarters since Q4 2025.

Larry Robbins's largest addition to Biogen Inc. (BIIB) was in Q4 2025, adding 290,605 shares worth $51.14 M.

According to the latest 13F filing for Q3 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 68,169 shares of Biogen Inc. (BIIB), valued at approximately $15.4 M.

As of the Q3 2026 filing, Biogen Inc. (BIIB) represents approximately 0.25% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.

Larry Robbins's peak holding in Biogen Inc. (BIIB) was 290,605 shares, as reported at the end of Q4 2025.